Opportunities for Innovation in HPV-Related Disease
SWHR hosted a virtual public forum on the need for innovation in HPV-related disease screening and treatment for women.
SWHR hosted a virtual public forum on the need for innovation in HPV-related disease screening and treatment for women.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
SWHR's webinar provides information about menopause for women and their health care providers as well as examine ways that we can individually and collectively improve the quality of life for women at this life stage.
The Duke-Margolis Center for Health Policy is convening a public meeting to discuss the need for clinical research in pregnant women as well as scientific and ethical considerations for the inclusion of this complex population in clinical trials.
SWHR and the Endocrine Society hosted a virtual congressional briefing to discuss the importance of including sex as a biological variable in research.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
This SWHR webinar provides valuable insight for both patients and health care providers on opportunities to empower individuals living with endometriosis.
The Congressional Caucus on Black Women and Girls hosted a virtual event, supported by SWHR, raising awareness of the astounding impact of uterine fibroids on the health of women.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
SWHR convened a working group of basic and clinical researchers, health care providers, patients/patient advocates, and policy leaders for a closed, two-day roundtable meeting to discuss the health, social, and economic impacts of alopecia, atopic dermatitis, and psoriatic arthritis on women.